ResMed’s AirSense 10, AirCurve 10 and Lumis products don’t infringe German utility model patent
MUNICH, March. 12, 2017 /PRNewswire/ — ResMed (New york stock exchange: RMD), the earth’s leading tech-driven medical device company and innovator in sleep-disordered breathing and respiratory system care, today announced that the Munich District Court made the decision that ResMed’s AirSense 10, AirCurve 10, Lumis as well as their humidifiers don’t infringe a Fisher & Paykel German utility model (a brief-term patent), DE 20 2013 012 358 U1.
Although ResMed’s products don’t infringe, ResMed continues its challenge from the validity from the German utility model prior to the German Patent and Trademark Office (GPTO).
Up to now, no German court finds that ResMed’s products infringe a Fisher & Paykel patent most of the three cases introduced by Fisher & Paykel against ResMed in Germany. By comparison, exactly the same German court concluded in September that Fisher & Paykel’s Simplus, Eson and Eson 2 masks infringe ResMed patents, while remaining the proceedings pending the end result of invalidation proceedings. ResMed has become protecting its very own patents within the European Patent Office.
“We applaud the German court because of its sensible approach,” stated ResMed global general counsel and chief administrative officer David Pendarvis. “We’re pleased the court found our products don’t infringe, and expect to showing this Fisher & Paykel patent is invalid.”
This ruling in Germany doesn’t have effect on ResMed and Fisher & Paykel’s patent violation litigation in other jurisdictions.
ResMed (New york stock exchange: RMD) changes lives with award-winning medical devices and cloud-based computer programs that better identify, treat and manage anti snoring, chronic obstructive lung disease (Chronic obstructive pulmonary disease) along with other chronic illnesses. ResMed is really a world leader in connected care, using more than 3 million patients remotely monitored every single day. Our 6,000-strong team is dedicated to allowing the world’s best tech-driven medical device company – improving quality of existence, lowering the impact of chronic disease, and saving healthcare costs in additional than 120 countries.
ResMed.com Facebook Twitter LinkedIn
View original content:http://world wide web.prnewswire.com/news-releases/resmed-wins-german-patent-violation-situation-introduced-by-fisher–paykel-300535631.html
SOURCE ResMed Corporation.
https://world wide web.resmed.com